You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carbon ion

Showing 26 - 50 of 1,624
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Pancreatic Adenocarcinoma Trial in Dallas, Chiba (Carbon Ion Radiation Therapy (CIRT), Intensity Modulated

Withdrawn
  • Locally Advanced Pancreatic Adenocarcinoma
  • Carbon Ion Radiation Therapy (CIRT)
  • Intensity Modulated Radiation Therapy (IMRT)
  • Dallas, Texas
  • +1 more
May 24, 2021

Sarcoma,Soft Tissue Trial in Heidelberg (Proton radiation, Carbon Ion radiation)

Recruiting
  • Sarcoma,Soft Tissue
  • Proton radiation
  • Carbon Ion radiation
  • Heidelberg, Germany
    University Hospital of Heidelberg, Radiation Oncology
Jun 21, 2021

Cancer of Pancreas, Pancreas Adenocarcinoma, Resectable Pancreatic Cancer Trial in Pavia (Preoperative chemo, Preoperative

Recruiting
  • Cancer of Pancreas
  • +2 more
  • Preoperative chemotherapy
  • Preoperative radiotherapy
  • Pavia, Italy
    CNAO
Aug 31, 2021

Locally Recurrent Nasopharyngeal Carcinoma Trial in Shanghai (Standardized CIRT, Individualized CIRT)

Not yet recruiting
  • Locally Recurrent Nasopharyngeal Carcinoma
  • Standardized CIRT
  • Individualized CIRT
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Oct 16, 2020

Pancreatic Cancer, Cancer Trial in Bronx, Shanghai (Carbon Ion, Gemcitabine + Cisplatin, Gemcitabine + Capecitabine)

Completed
  • Pancreatic Cancer
  • Cancer
  • Carbon Ion
  • +5 more
  • Bronx, New York
  • +1 more
Apr 21, 2020

Primary Glioblastoma Trial in Heidelberg (Carbon Ion Radiotherapy, Proton Radiotherapy)

Completed
  • Primary Glioblastoma
  • Carbon Ion Radiotherapy
  • Proton Radiotherapy
  • Heidelberg, Germany
    University Hospital of Heidelberg, Department of Radiation Oncol
Apr 2, 2020

Pancreatic Carcinoma Trial in Shanghai (proton and carbon ion radiotherapy)

Completed
  • Pancreatic Carcinoma
  • proton and carbon ion radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Mar 4, 2020

Nasopharyngeal Carcinoma Trial in Shanghai (Carbon ion radiotherapy (CIRT))

Terminated
  • Nasopharyngeal Carcinoma
  • Carbon ion radiotherapy (CIRT)
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Feb 12, 2020

FLT PET/CT for LR-NPC Treated by Carbon Ion Therapy

Not yet recruiting
  • Recurrent Nasopharyngeal Carcinoma
  • FLT PET/CT
  • (no location specified)
Apr 3, 2020

Nasopharyngeal Carcinoma Trial in Shanghai (Carbon ion radiotherapy (CIRT), Cisplatin)

Terminated
  • Nasopharyngeal Carcinoma
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Feb 12, 2020

Nasopharyngeal Carcinoma Trial in Shanghai (Carbon ion radiotherapy (CIRT))

Unknown status
  • Nasopharyngeal Carcinoma
  • Carbon ion radiotherapy (CIRT)
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Feb 12, 2020

Hepatocellular Carcinoma Trial in Shanghai (carbon-ion radiotherapy)

Withdrawn
  • Hepatocellular Carcinoma
  • carbon-ion radiotherapy
  • Shanghai, Shanghai, China
  • +1 more
Sep 5, 2019

Metal-ions in the PEEK HD Coupling Mechanism of the Knee

Not yet recruiting
  • Mutars
  • +6 more
  • Blood sample analysis
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Center
Jun 5, 2023

Soft Tissue Sarcoma Trial in Heidelberg (Protons, carbon ions)

Recruiting
  • Soft Tissue Sarcoma
  • Protons
  • carbon ions
  • Heidelberg, Baden-Württemberg, Germany
    University Hospital Heidelberg, Department of RadioOncology
Jun 30, 2021

Mechanical Ventilation, General Anesthesia, Urological Surgery Trial in Guangzhou (record Hemodynamic variables, respiratory

Completed
  • Mechanical Ventilation
  • +3 more
  • record Hemodynamic variables, respiratory variables and arterial blood gas at specific times
  • Guangzhou, Guangdong, China
    Cai Xinyuan
Sep 20, 2023

Glioblastoma Trial in Shanghai (Radiotherapy)

Not yet recruiting
  • Glioblastoma
  • Radiotherapy
  • Shanghai, Shanghai, China
    Shanghai Proton and Heavy Ion Center
Aug 28, 2020

Healthy, Kidney Stone, Obesity Trial in Birmingham (Low-oxalate controlled diet, Primed, continuous intravenous infusion of

Recruiting
  • Healthy
  • +2 more
  • Low-oxalate controlled diet
  • Primed, continuous intravenous infusion of 13C2-oxalate
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 21, 2022

Healthy Trial in Ottignies-Louvain-la-Neuve, Woluwe-Saint-Lambert (Screening visit, Lactulose test, Administration of

Recruiting
  • Healthy
  • Screening visit
  • +2 more
  • Ottignies-Louvain-la-Neuve, Brabant Wallon, Belgium
  • +2 more
Jul 13, 2023

Endoscopic Retrograde Cholangiopancreatography Patients

Recruiting
  • Patient Monitoring
  • propofol (2 mg/kg) and fentanyl (1ug/kg) and 4 liters O2 flow through nasal cannula
  • Assiut, Egypt
  • +1 more
Feb 14, 2022

Carbon Dioxide Trial in Assiut (DualGuard)

Completed
  • Carbon Dioxide
  • DualGuard
  • Assiut, Egypt
    Assiut university
Mar 4, 2022

Kidney Diseases, Metabolic Acidosis, Renal Insufficiency Trial in Hillerød (Low PRAL)

Recruiting
  • Kidney Diseases
  • +4 more
  • Low PRAL
  • Hillerød, Denmark
    Nordshjaellands Hospital
Mar 27, 2023

Healthy Trial in Birmingham (Low oxalate controlled Diet, Primed, continuous intravenous infusion of 13C2-Glycolate, Bolus

Recruiting
  • Healthy
  • Low oxalate controlled Diet
  • +3 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 5, 2021

Innovative SolutIons for DosimEtry in Hadrontherapy (INSIDE)

Recruiting
  • Particle Therapy
  • carbon ions radiation therapy
  • protons radiation therapy
  • Pavia, Italy
    CNAO
May 20, 2021

Lateral 45° Downward Position on the Optic Nerve Sheath Diameter

Completed
  • Optic Nerve Sheath Diameter
  • Measurement of the optic nerve sheath diameter by ultrasound-guidance.
  • (no location specified)
Dec 22, 2021

Unresectable Sinonasal Tumors Trial in Italy (Cisplatin, Docetaxel, 5-fluorouracil)

Active, not recruiting
  • Unresectable Sinonasal Tumors
  • Brescia, BS, Italy
  • +4 more
Apr 8, 2022